애보트 연구소
US ˙ NYSE ˙ US0028241000

SecurityABT / Abbott Laboratories
InstitutionUsca Ria Llc
Latest Disclosed Ownership18,767 shares
Latest Disclosed Value $ 2,176,000
Usca Ria Llc reports 3.09% increase in ownership of ABT / Abbott Laboratories

On July 28, 2021 - Usca Ria Llc filed a 13F-HR form disclosing ownership of 18,767 shares of Abbott Laboratories (US:ABT) valued at $2,175,658 USD as of June 30, 2021. The entity filed a previous 13F-HR on April 27, 2021 disclosing 18,205 shares of Abbott Laboratories. This represents a change in shares of 3.09% during the quarter. The current value of the position is $1,709,111 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2021-07-28 2021-06-30 13F ABBOTT LABS COM 002824100 18,767 562 3.09 2,176 -0.27 0.1320
2021-04-27 2021-03-31 13F ABBOTT LABS COM 002824100 18,205 -10 -0.05 2,182 9.43 0.1434
2021-01-27 2020-12-31 13F ABBOTT LABS COM 002824100 18,215 -7,042 -27.88 1,994 -27.46 0.1400
2020-10-27 2020-09-30 13F ABBOTT LABS COM 002824100 25,257 66 0.26 2,749 19.37 0.2155
2020-08-13 2020-06-30 13F ABBOTT LABS COM 002824100 25,191 2,764 12.32 2,303 30.11 0.2037
2020-04-22 2020-03-31 13F/A-2 ABBOTT LABS COM 002824100 22,427 895 4.16 1,770 -5.35 0.2053
2020-04-22 2020-03-31 13F/A-1 ABBOTT LABS COM 002824100 121,457 99,030 9,584 0.5995
2020-01-27 2019-12-31 13F ABBOTT LABS COM 002824100 21,532 125 0.58 1,870 4.41 0.1673
2019-11-07 2019-09-30 13F/A-1 ABBOTT LABS COM 002824100 21,407 2,158 11.21 1,791 10.62 0.1761
2019-10-31 2019-09-30 13F ABBOTT LABORATORIES COM 002824100 21,407 2,158 1,791 170,925.2834
2019-08-14 2019-06-30 13F/A-1 ABBOTT LABS COM 002824100 19,249 202 1.06 1,619 6.30 0.1643
2019-08-02 2019-06-30 13F ABBOTT LABS COM 002824100 19,249 19,249 1,619
2019-08-14 2019-03-31 13F/A-1 ABBOTT LABS COM 002824100 19,047 697 3.80 1,523 14.77 0.1657
2019-02-12 2018-12-31 13F ABBOTT LABS COM 002824100 18,350 68 0.37 1,327 -1.04 0.1766
2018-11-02 2018-09-30 13F ABBOTT LABS COM 002824100 18,282 -1,734 -8.66 1,341 9.83 0.1366
2018-08-08 2018-06-30 13F ABBOTT LABS COM 002824100 20,016 -1,378 -6.44 1,221 -4.76 0.1311
2018-05-09 2018-03-31 13F ABBOTT LABS COM 002824100 21,394 2,995 16.28 1,282 22.10 0.1412
2018-02-09 2017-12-31 13F ABBOTT LABS COM 002824100 18,399 1,014 5.83 1,050 24.26 0.1159
2017-11-07 2017-09-30 13F ABBOTT LABS COM 002824100 17,385 0 0.00 845 0.00 0.1093
2017-08-07 2017-06-30 13F ABBOTT LABS COM 002824100 17,385 -35,557 -67.16 845 -64.06 0.1082
2017-05-01 2017-03-31 13F ABBOTT LABS COM 002824100 52,942 16,367 44.75 2,351 67.33 0.3448
2017-02-09 2016-12-31 13F ABBOTT LABS COM 002824100 36,575 -828 -2.21 1,405 -11.19 0.2163
2016-11-15 2016-09-30 13F ABBOTT LABS COM 002824100 37,403 468 1.27 1,582 8.95 0.2621
2016-08-13 2016-06-30 13F ABBOTT LABS COM 002824100 36,935 -7,044 -16.02 1,452 -21.09 0.2440
2016-05-23 2016-03-31 13F/A-1 ABBOTT LABS COM 002824100 43,979 16,561 60.40 1,840 49.47 0.3337
2016-05-16 2016-03-31 13F ABBOTT LABS COM 002824100 1,839,654 43,979
2016-02-08 2015-12-31 13F ABBOTT LABS COM 002824100 27,418 1,000 3.79 1,231 15.80 0.2659
2015-11-13 2015-09-30 13F ABBOTT LABS COM 002824100 26,418 277 1.06 1,063 -17.15 0.2668
2015-09-17 2015-06-30 13F/A-1 ABBOTT LABS COM 002824100 26,141 -6 -0.02 1,283 5.95 0.3402
2015-08-12 2015-06-30 13F ABBOTT LABS COM 002824100 25,011 963
2015-09-17 2015-03-31 13F/A-1 ABBOTT LABS COM 002824100 26,147 109 0.42 1,211 3.33 0.3246
2015-06-03 2015-03-31 13F ABBOTT LABS COM 002824100 25,011 963
2015-02-11 2014-12-31 13F ABBOTT LABS COM 002824100 26,038 1,221 4.92 1,172 13.57 0.3237
2014-11-14 2014-09-30 13F ABBOTT LABS COM 002824100 24,817 4 0.02 1,032 1.67 0.3145
2014-08-28 2014-06-30 13F ABBOTT LABS COM 002824100 24,813 -198 -0.79 1,015 5.40 0.3403
2014-05-12 2014-03-31 13F ABBOTT LABS COM 002824100 25,011 6 0.02 963 0.52 0.3459
2014-02-05 2013-12-31 13F ABBOTT LABS COM 002824100 25,005 9,904 65.59 958 91.22 0.3824
2013-11-14 2013-09-30 13F ABBOTT LABS COM 002824100 15,101 0 0.00 501 -4.93 0.2279
2013-08-19 2013-06-30 13F ABBOTT LABS COM 002824100 15,101 15,101 527 0.2647
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.